Publications

Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

 83
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

Tags:

Previous Article

Opposing roles for AMPK in regulating distinct mitophagy pathways

Next Article

Gene replacement therapy for hereditary spastic paraplegia type 47

Related Posts

Targeting cholesterol-dependent adrenal steroidogenesis for management of primary aldosteronism

Targeting cholesterol-dependent adrenal steroidogenesis...

 68

A decision-space model explains context- specific decision-making

A decision-space model explains context- specific decis...

 77

Activity-attenuated serum albumin-fused interleukin-33 suppresses experimental autoimmune encephalomyelitis

Activity-attenuated serum albumin-fused interleukin-33 ...

 53